Benjamin F. Edwards & Company, Inc. Optimize Rx Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Optimize Rx Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 248 shares of OPRX stock, worth $4,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248
Previous 431
42.46%
Holding current value
$4,645
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding OPRX
# of Institutions
133Shares Held
13.6MCall Options Held
223KPut Options Held
92.8K-
Whetstone Capital Advisors, LLC Shawnee Mission, KS1.51MShares$28.3 Million7.42% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA921KShares$17.2 Million0.0% of portfolio
-
Royce & Associates LP791KShares$14.8 Million0.12% of portfolio
-
Blair William & CO Chicago, IL629KShares$11.8 Million0.02% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $338M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...